Clinical trials in Toledo, OH

39 recruiting studies have a site in or near Toledo, OH, Ohio.

Top conditions here

All conditions

Showing 39 of 39 studies

RecruitingPhase 3NCT04267848

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Sponsor: National Cancer Institute (NCI)

Akron, OH · Alliance, OH · Beavercreek, OH · +1147 more sites

RecruitingPhase 2NCT06317662

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Sponsor: National Cancer Institute (NCI)

Akron, OH · Cincinnati, OH · Cleveland, OH · +112 more sites

RecruitingNot applicableNCT07574593

NORM-HF Pivotal Study

Sponsor: Foundry Innovation & Research 1, Limited (FIRE1)

Cincinnati, OH · Colombus, OH · Toledo, OH · +22 more sites

RecruitingPhase 3NCT06023589

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

Sponsor: AstraZeneca

Cincinnati, OH · Cleveland, OH · Toledo, OH · +27 more sites

RecruitingPhase 3NCT06307665

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Sponsor: AstraZeneca

Cincinnati, OH · Columbus, OH · +117 more sites

RecruitingPhase 2NCT06977581

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

Sponsor: Pfizer

Toledo, OH · +35 more sites

RecruitingPhase not listedNCT07556159

A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

Sponsor: Sanofi

Lima, OH · Toledo, OH · +61 more sites

RecruitingPhase 2NCT05967689

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

Sponsor: Taiho Oncology, Inc.

Canton, OH · Columbus, OH · Toledo, OH · +15 more sites

RecruitingNot applicableNCT06812533

Alleviant ALLAY-HFrEF Study

Sponsor: Alleviant Medical, Inc.

Cleveland, OH · Toledo, OH · +38 more sites

RecruitingPhase 2NCT07323654

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

Sponsor: Kymera Therapeutics, Inc.

Toledo, OH · +33 more sites

RecruitingPhase 3NCT06283966

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Sponsor: AstraZeneca

Beavercreek, OH · Blue Ash, OH · Cleveland, OH · +232 more sites

RecruitingPhase 3NCT07190222

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Sponsor: Sanofi

Toledo, OH · +75 more sites

RecruitingPhase 2NCT06932263

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

Sponsor: AstraZeneca

Toledo, OH · +63 more sites

RecruitingPhase 3NCT06357533

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Sponsor: AstraZeneca

Cincinnati, OH · Columbus, OH · Maumee, OH · +60 more sites

RecruitingPhase not listedNCT06433752

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Sponsor: TG Therapeutics, Inc.

Centerville, OH · Cincinnati, OH · +106 more sites

RecruitingPhase 3NCT07184931

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Sanofi

Canton, OH · Cleveland, OH · Columbus, OH · +122 more sites

RecruitingPhase 3NCT04293562

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Sponsor: Children's Oncology Group

Akron, OH · Cincinnati, OH · Cleveland, OH · +183 more sites

RecruitingPhase 3NCT06677060

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Sponsor: AstraZeneca

Beavercreek, OH · Canton, OH · Cincinnati, OH · +195 more sites

RecruitingPhase not listedNCT05059444

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Sponsor: Guardant Health, Inc.

Cincinnati, OH · Cleveland, OH · Toledo, OH · +30 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Akron, OH · Alliance, OH · +1223 more sites

RecruitingPhase 2 / Phase 3NCT07363694

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Sponsor: Pfizer

Toledo, OH · +60 more sites

RecruitingPhase 1 / Phase 2NCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Sponsor: PedAL BCU, LLC

Akron, OH · Cincinnati, OH · Cleveland, OH · +161 more sites

RecruitingPhase not listedNCT00271180

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Sponsor: Medtronic

Akron, OH · Cincinnati, OH · Cleveland, OH · +110 more sites

RecruitingPhase 3NCT07184996

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Sponsor: Sanofi

Canton, OH · Columbus, OH · +115 more sites

RecruitingPhase not listedNCT04398628

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Sponsor: American Thrombosis and Hemostasis Network

Akron, OH · Cincinnati, OH · +73 more sites

RecruitingNot applicableNCT05685303

Alleviant ALLAY-HF Study

Sponsor: Alleviant Medical, Inc.

Cleveland, OH · Toledo, OH · +54 more sites

RecruitingPhase 3NCT06801834

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

Sponsor: Gilead Sciences

Sandusky, OH · Toledo, OH · +21 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Akron, OH · Athens, OH · Avon, OH · +825 more sites

RecruitingPhase 3NCT06748222

E-Mindfulness Approaches for Living After Breast Cancer

Sponsor: NRG Oncology

Beavercreek, OH · Cincinnati, OH · Columbus, OH · +378 more sites

RecruitingPhase 3NCT06944522

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Sponsor: BlueRock Therapeutics

Toledo, OH · +33 more sites

RecruitingPhase 3NCT06592924

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Sponsor: Canadian Cancer Trials Group

Akron, OH · Avon, OH · Beachwood, OH · +371 more sites

RecruitingPhase 2NCT05642572

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Sponsor: SWOG Cancer Research Network

Belpre, OH · Canton, OH · +451 more sites

RecruitingPhase not listedNCT07228026

Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects

Sponsor: Biometry Inc

Toledo, OH · +12 more sites

RecruitingPhase 2 / Phase 3NCT03851445

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Sponsor: SWOG Cancer Research Network

Alliance, OH · Athens, OH · Beachwood, OH · +1226 more sites

RecruitingPhase 3NCT06747949

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

Sponsor: Amgen

Miamisburg, OH · Toledo, OH · Vandalia, OH · +28 more sites

RecruitingPhase 3NCT04852887

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Sponsor: NRG Oncology

Akron, OH · Avon, OH · +809 more sites

RecruitingPhase 2NCT07033026

An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

Sponsor: NGM Biopharmaceuticals, Inc

Toledo, OH · Youngstown, OH · +11 more sites

RecruitingPhase 3NCT05929768

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Sponsor: SWOG Cancer Research Network

Akron, OH · Alliance, OH · Barberton, OH · +952 more sites

RecruitingPhase not listedNCT05234177

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Sponsor: Tempus AI

Canton, OH · Cincinnati, OH · Columbus, OH · +17 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.